The survival benefit of low molecular weight heparin over unfractionated heparin in pediatric trauma patients

This retrospective analysis of 1,678 pediatric trauma patients demonstrates that low molecular weight heparin (LMWH) significantly outperforms unfractionated heparin (UFH) in patients aged 10-17 years, with lower mortality (1.4% vs 3.6%), reduced DVT rates (1.7% vs 3.7%), and shorter hospital stays (7 vs 9 days).